Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Helsinn Healthcare SA

Switzerland

CMS manufacturer 100000000288

Open in the dashboard

General payments

$4,523,939

515 payments

Research payments

$6,229,615

780 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Helsinn Healthcare SA reported paying $4,523,939 in general payments and $6,229,615 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

13 rows
Year Kind Amount Payments
2025 General $287,847 26
2024 General $296,607 40
2024 Research $79,449 5
2023 General $315,175 37
2023 Research $969,868 155
2022 General $314,811 37
2022 Research $1,276,091 138
2021 General $309,187 40
2021 Research $540,223 118
2020 General $1,749,765 109
2020 Research $1,552,466 162
2019 General $1,250,547 226
2019 Research $1,811,518 202

Breakdown

Top recipients General payments · program year 2025
  1. Timothy Henkel Infectious Disease · Hilton Head Island, SC $175,582 4 payments
  2. H Wilkins Family Medicine · Sellersville, PA $86,692 4 payments
  3. Larisa Geskin Dermatology · New York, NY $6,947 5 payments
  4. Philip Schein Medical Oncology · Bryn Mawr, PA $6,430 4 payments
  5. Christiane Querfeld Dermatopathology · Duarte, CA $6,399 4 payments
  6. Oleg Akilov Dermatology · Pittsburgh, PA $5,796 5 payments
Top research recipients Research payments · program year 2024
  1. Uci Medical Center Teaching hospital · CA $67,720 3 payments
  2. Henry Ford Hospital Teaching hospital · MI $11,729 2 payments
Products the payments named General payments · program year 2025
  1. Valchlor Oncology $287,847 100% · 6 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Infectious Disease Internal Medicine $175,582 61% · 1 practitioner
  2. Family Medicine $86,692 30% · 1 practitioner
  3. Dermatology $12,743 4% · 2 practitioners
  4. Medical Oncology Internal Medicine $6,430 2% · 1 practitioner
  5. Dermatopathology Dermatology $6,399 2% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. South Carolina $175,582 61% · 1 recipient
  2. Pennsylvania $98,919 34% · 3 recipients
  3. New York $6,947 2% · 1 recipient
  4. California $6,399 2% · 1 recipient

Each share is of this company’s general payments in 2025 where a state was reported.

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,673,066 136 payments
  2. Grant $1,003,312 8 payments
  3. Consulting Fee $652,201 133 payments
  4. Travel and Lodging $191,447 148 payments
  5. Food and Beverage $3,913 90 payments
Companies with a similar name General payments · program years 2019–2025
  1. Helsinn Therapeutics (U.S.), Inc. NJ, United States $1,172,492

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

515 general · 780 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record